1 2250 172 THE LONGITUDINAL EFFECTS OF SEATED ISOMETRIC YOGA ON BLOOD BIOMARKERS, AUTONOMIC FUNCTIONS, AND PSYCHOLOGICAL PARAMETERS OF PATIENTS WITH CHRONIC FATIGUE SYNDROME: A PILOT STUDY. BACKGROUND: IN A PREVIOUS RANDOMIZED CONTROLLED TRIAL, WE FOUND THAT PRACTICING SEATED ISOMETRIC YOGA REGULARLY FOR 2 MONTHS IMPROVED THE FATIGUE OF PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) WHO ARE RESISTANT TO CONVENTIONAL THERAPY. THE AIM OF THIS PILOT STUDY WAS TO INVESTIGATE THE POSSIBLE MECHANISMS BEHIND THIS FINDING BY COMPARING BLOOD BIOMARKERS, AUTONOMIC NERVOUS FUNCTION, AND PSYCHOLOGICAL INDICES BEFORE VERSUS AFTER AN INTERVENTION PERIOD OF SEATED ISOMETRIC YOGA PRACTICE. METHODS: FIFTEEN PATIENTS WITH CFS WHO DID NOT SHOW SATISFACTORY IMPROVEMENTS AFTER AT LEAST 6 MONTHS OF CONVENTIONAL THERAPY PRACTICED SEATED ISOMETRIC YOGA (BIWEEKLY 20-MIN SESSIONS WITH A YOGA INSTRUCTOR AND DAILY PRACTICE AT HOME) FOR 2 MONTHS. THE LONGITUDINAL EFFECTS OF SEATED ISOMETRIC YOGA ON FATIGUE, BLOOD BIOMARKERS, AUTONOMIC FUNCTION, AND PSYCHOLOGICAL STATE WERE INVESTIGATED BY COMPARING THE FOLLOWING PARAMETERS BEFORE AND AFTER THE INTERVENTION PERIOD: FATIGUE SEVERITY WAS ASSESSED BY THE CHALDER FATIGUE SCALE (FS) SCORE. LEVELS OF THE BLOOD BIOMARKERS CORTISOL, DHEA-S, TNF-ALPHA, IL-6, PROLACTIN, CARNITINE, TGF-BETA1, BDNF, MHPG, HVA, AND ALPHA-MSH WERE MEASURED. THE AUTONOMIC NERVOUS FUNCTIONS ASSESSED WERE HEART RATE (HR) AND HR VARIABILITY. PSYCHOLOGICAL INDICES INCLUDED THE 20-ITEM TORONTO ALEXITHYMIA SCALE (TAS-20) AND THE HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS). RESULTS: PRACTICING SEATED ISOMETRIC YOGA FOR 2 MONTHS RESULTED IN SIGNIFICANT REDUCTIONS IN THE CHALDER FS (P = 0.002) AND HADS-DEPRESSION (P = 0.02) SCORES. NO SIGNIFICANT CHANGES WERE OBSERVED IN ANY OTHER PARAMETER EVALUATED. THE CHANGE IN CHALDER FS SCORE WAS NOT CORRELATED WITH THE CHANGE IN HADS-DEPRESSION SCORE. HOWEVER, THIS CHANGE WAS POSITIVELY CORRELATED WITH CHANGES IN THE SERUM TNF-ALPHA LEVELS (P = 0.048), THE HIGH FREQUENCY COMPONENT OF HR VARIABILITY (P = 0.042), AND TAS-20 SCORES (P = 0.001). CONCLUSIONS: REGULAR PRACTICE OF SEATED ISOMETRIC YOGA FOR 2 MONTHS REDUCED THE FATIGUE AND DEPRESSIVE SYMPTOM SCORES OF PATIENTS WITH CFS WITHOUT AFFECTING ANY OTHER PARAMETERS WE INVESTIGATED. THIS STUDY FAILED TO IDENTIFY THE MARKERS RESPONSIBLE FOR THE LONGITUDINAL FATIGUE-RELIEVING EFFECT OF SEATED ISOMETRIC YOGA. HOWEVER, CONSIDERING THAT THE REDUCED FATIGUE WAS ASSOCIATED WITH DECREASED SERUM TNF-ALPHA LEVEL AND TAS-20 SCORES, FATIGUE IMPROVEMENT MIGHT BE RELATED TO REDUCED INFLAMMATION AND IMPROVED ALEXITHYMIA IN THESE PATIENTS. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. REGISTERED DEC 27, 2012. 2019 2 451 111 CHANGES IN FATIGUE, AUTONOMIC FUNCTIONS, AND BLOOD BIOMARKERS DUE TO SITTING ISOMETRIC YOGA IN PATIENTS WITH CHRONIC FATIGUE SYNDROME. BACKGROUND: IN A PREVIOUS RANDOMIZED CONTROLLED TRIAL, WE FOUND THAT SITTING ISOMETRIC YOGA IMPROVES FATIGUE IN PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) WHO ARE RESISTANT TO CONVENTIONAL THERAPY. THE AIM OF THIS STUDY WAS TO INVESTIGATE POSSIBLE MECHANISMS BEHIND THIS FINDING, FOCUSING ON THE SHORT-TERM FATIGUE-RELIEVING EFFECT, BY COMPARING AUTONOMIC NERVOUS FUNCTION AND BLOOD BIOMARKERS BEFORE AND AFTER A SESSION OF ISOMETRIC YOGA. METHODS: FIFTEEN PATIENTS WITH CFS WHO REMAINED SYMPTOMATIC DESPITE AT LEAST 6 MONTHS OF CONVENTIONAL THERAPY PRACTICED SITTING ISOMETRIC YOGA (BIWEEKLY 20 MIN PRACTICE WITH A YOGA INSTRUCTOR AND DAILY HOME PRACTICE) FOR EIGHT WEEKS. ACUTE EFFECTS OF SITTING ISOMETRIC YOGA ON FATIGUE, AUTONOMIC FUNCTION, AND BLOOD BIOMARKERS WERE INVESTIGATED AFTER THE FINAL SESSION WITH AN INSTRUCTOR. THE EFFECT OF A SINGLE SESSION OF SITTING ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY THE PROFILE OF MOOD STATUS (POMS) QUESTIONNAIRE IMMEDIATELY BEFORE AND AFTER THE SESSION. AUTONOMIC NERVOUS FUNCTION (HEART RATE (HR) VARIABILITY) AND BLOOD BIOMARKERS (CORTISOL, DHEA-S, TNF-ALPHA, IL-6, IFN-GAMMA, IFN-ALPHA, PROLACTIN, CARNITINE, TGF-BETA1, BDNF, MHPG, AND HVA) WERE COMPARED BEFORE AND AFTER THE SESSION. RESULTS: SITTING ISOMETRIC YOGA SIGNIFICANTLY REDUCED THE POMS FATIGUE SCORE (P < 0.01) AND INCREASED THE VIGOR SCORE (P < 0.01). IT ALSO REDUCED HR (P < 0.05) AND INCREASED THE HIGH FREQUENCY POWER (P < 0.05) OF HR VARIABILITY. SITTING ISOMETRIC YOGA INCREASED SERUM LEVELS OF DHEA-S (P < 0.05), REDUCED LEVELS OF CORTISOL (P < 0.05) AND TNF-ALPHA (P < 0.05), AND HAD A TENDENCY TO REDUCE SERUM LEVELS OF PROLACTIN (P < 0.1). DECREASES IN FATIGUE SCORES CORRELATED WITH CHANGES IN PLASMA LEVELS OF TGF-BETA1 AND BDNF. IN CONTRAST, INCREASED VIGOR POSITIVELY CORRELATED WITH HVA. CONCLUSIONS: A SINGLE SESSION OF SITTING ISOMETRIC YOGA REDUCED FATIGUE AND INCREASED VIGOR IN PATIENTS WITH CFS. YOGA ALSO INCREASED VAGAL NERVE FUNCTION AND CHANGED BLOOD BIOMARKERS IN A PATTERN THAT SUGGESTED ANTI-STRESS AND ANTI-INFLAMMATORY EFFECTS. THESE CHANGES APPEAR TO BE RELATED TO THE SHORT-TERM FATIGUE-RELIEVING EFFECT OF SITTING ISOMETRIC YOGA IN PATIENTS WITH CFS. FURTHERMORE, DOPAMINERGIC NERVOUS SYSTEM ACTIVATION MIGHT ACCOUNT FOR SITTING ISOMETRIC YOGA-INDUCED INCREASES IN ENERGY IN THIS PATIENT POPULATION. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. REGISTERED DEC 27, 2012. 2018 3 2071 44 THE EFFECT OF A SINGLE YOGA CLASS ON INTEROCEPTIVE ACCURACY IN PATIENTS AFFECTED BY ANOREXIA NERVOSA AND IN HEALTHY CONTROLS: A PILOT STUDY. PURPOSE: TO EVALUATE INTEROCEPTIVE ACCURACY (IAC) BEFORE AND AFTER A SINGLE YOGA CLASS IN A POPULATION OF PATIENTS WITH ANOREXIA NERVOSA (AN) AND IN A POPULATION OF HEALTHY CONTROLS (HC). METHODS: FIFTEEN PATIENTS WITH AN AND TWENTY HC WERE INCLUDED IN THE STUDY. ALL INDIVIDUALS PARTICIPATED IN A SINGLE YOGA CLASS. BEFORE (T0) AND AFTER (T1) THE YOGA CLASS, THEY UNDERWENT THE HEARTBEAT DETECTION TASK FOR THE EVALUATION OF IAC. AT T0, ALL PARTICIPANTS ALSO UNDERWENT A PSYCHOLOGICAL ASSESSMENT, INCLUDING EVALUATION OF DEPRESSION, ANXIETY, BODY AWARENESS, ALEXITHYMIA, SELF-OBJECTIFICATION AND EATING DISORDERS PSYCHOPATHOLOGY. RESULTS: PATIENTS WITH AN HAD LOWER IAC THAN HC AT T0. A SIGNIFICANT IMPROVEMENT OF IAC AT T1 WAS FOUND IN THE HC GROUP BUT NOT IN THE GROUP OF PATIENTS WITH AN. CONCLUSION: WE INFER THAT OUR FINDINGS MIGHT BE LINKED TO THE FACT THAT PATIENTS WITH AN, DIFFERENTLY FROM HC, DID NOT PROPERLY ATTEND TO THEIR BODIES, DESPITE THE YOGA CLASS. THIS HYPOTHESIS IS CONSISTENT WITH PREVIOUS STUDIES SHOWING THAT PATIENTS WITH AN HAVE DECREASED IAC DURING SELF-FOCUSED BEHAVIOR BECAUSE OF BODY-RELATED AVOIDANCE. MOREOVER, WE SURMISE THAT HC MIGHT BE KEENER TO IMPROVE THEIR PERCEPTION OF INTERNAL BODY SIGNALS EVEN AFTER A SINGLE YOGA CLASS BECAUSE THEIR EMOTIONAL AWARENESS SYSTEM IS NOT IMPAIRED. PATIENTS WITH AN, ON THE CONTRARY, MAY HAVE AN INTRINSIC IMPAIRMENT OF THEIR EMOTIONAL AWARENESS, MAKING IT HARDER FOR THEM TO MODULATE THEIR IAC. LEVEL OF EVIDENCE: LEVEL III, EVIDENCE OBTAINED FROM WELL-DESIGNED COHORT OR CASE-CONTROL ANALYTICAL STUDIES. 2021 4 1470 31 INNOVATIVE INTERVENTIONS FOR DISORDERED EATING: EVALUATING DISSONANCE-BASED AND YOGA INTERVENTIONS. OBJECTIVE: EATING-DISORDERED BEHAVIOR IS PREVALENT AMONG COLLEGE WOMEN. FEW INTERVENTIONS HAVE SUCCESSFULLY REDUCED RISK FACTORS FOR THESE BEHAVIORS, HOWEVER. THE MOST PROMISING INTERVENTIONS ARE BOTH SELECTIVE AND INTERACTIVE. THIS STUDY COMPARED TWO NEWER TYPES OF INTERVENTIONS THAT MEET THESE CRITERIA: COGNITIVE DISSONANCE AND YOGA PROGRAMS. METHOD: THIS STUDY ADVERTISED PROGRAMS FOR WOMEN WHO WERE DISSATISFIED WITH THEIR BODIES. PARTICIPANTS (N = 93) WERE RANDOMLY ASSIGNED TO DISSONANCE, YOGA, OR CONTROL GROUPS. RESULTS: HIERARCHICAL REGRESSION ANALYSES REVEALED THAT THERE WERE NO SIGNIFICANT POST-INTERVENTION DIFFERENCES BETWEEN THE YOGA AND CONTROL GROUPS. DISSONANCE GROUP PARTICIPANTS HAD SIGNIFICANTLY LOWER SCORES THAN THE SCORES OF BOTH OTHER GROUPS ON MEASURES OF DISORDERED EATING, DRIVE FOR THINNESS, BODY DISSATISFACTION, ALEXITHYMIA, AND ANXIETY. CONCLUSION: THESE FINDINGS HAVE IMPORTANT IMPLICATIONS FOR INTERVENTIONS ON COLLEGE CAMPUSES. IN PARTICULAR, DISSONANCE INTERVENTIONS APPEAR TO BE AN EFFICIENT AND INEXPENSIVE APPROACH TO REDUCING EATING DISORDER RISK FACTORS. ADDITIONAL RESEARCH REGARDING THE VALUE OF YOGA INTERVENTIONS IS NEEDED. 2007 5 957 41 EFFECTS OF A SINGLE YOGA SESSION ON CARDIAC INTEROCEPTIVE ACCURACY AND EMOTIONAL EXPERIENCE. BACKGROUND: THERE IS AN INCREASING BODY OF RESEARCH SUPPORTING THE IDEA THAT CARDIAC INTEROCEPTIVE ACCURACY (IAC) CAN BE IMPROVED BY TRAINING. FINDINGS CONCERNING THE EFFECTS OF A SINGLE YOGA SESSION ON IAC AND THE RELATED CONSTRUCT EMOTIONAL EXPERIENCE ARE SPARSE. THE AIM OF THIS STUDY WAS TO EXAMINE IF A SINGLE YOGA SESSION INCREASES IAC AND IMPROVES EMOTIONAL EXPERIENCE. METHODS: 137 STUDENTS WERE RANDOMLY ASSIGNED TO A 20-MIN YOGA SESSION (N = 47), AN ENDURANCE SESSION (N = 46), OR AN INACTIVE CONTROL CONDITION (N = 44). IAC AND EMOTIONAL EXPERIENCE WERE ASSESSED BEFORE AND AFTER THE SESSIONS. RESULTS: THERE WERE NO SIGNIFICANT CHANGES IN IAC, OR POSITIVE AND NEGATIVE AFFECT. IAC AT BASELINE AND THE CHANGE IN POSITIVE EFFECT WERE FOUND AS PREDICTORS FOR IAC AFTER THE YOGA SESSION. CONCLUSION: A 20-MIN YOGA SESSION SEEMS TO BE NOT APPLICABLE TO IMPROVE IAC AND EMOTIONAL EXPERIENCE. FUTURE STUDIES SHOULD INVESTIGATE LONG-TERM INTERVENTIONS AND DIVERSE HEALTHY AND CLINICAL POPULATIONS. 2021 6 1483 40 INTEGRATING YOGA WITH PSYCHOLOGICAL GROUP-TREATMENT FOR MIXED DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE: AN EXPLORATIVE PILOT STUDY. BACKGROUND AND PURPOSE: YOGA HAS SHOWN PROMISE AS A TREATMENT FOR DEPRESSION AND ANXIETY. THE PRESENT PILOT STUDY INVESTIGATED THE FEASIBILITY OF AN EIGHT-WEEK GROUPTREATMENT INTEGRATING EMOTION-FOCUSED PSYCHOEDUCATION, COMPASSION-FOCUSED THERAPY, AND VIRYA YOGA FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. MATERIALS AND METHODS: PATIENTS SEEKING TREATMENT FOR DEPRESSION AND ANXIETY IN A PRIMARY HEALTHCARE CENTRE COMPLETED EITHER AN INTEGRATIVE GROUP-TREATMENT (N = 14) OR TREATMENT AS USUAL (TAU, N = 17). OUTCOME MEASURES WERE ANALYSED PRE- AND POSTTREATMENT. CORRELATIONS IN THE INTERVENTION GROUP WERE INVESTIGATED BETWEEN TREATMENT OUTCOMES AND AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. RESULTS: LARGE WITHIN-GROUP EFFECT SIZES ON ALL OUTCOME MEASURES WERE FOUND AT POSTTREATMENT. SYMPTOM REDUCTION DID NOT DIFFER BETWEEN GROUPS (P = 0.155). IMPROVEMENT IN ALEXITHYMIA CORRELATED SIGNIFICANTLY (P < 0.05) WITH AMOUNT OF YOGA PRACTICE BETWEEN SESSIONS. CONCLUSION: INTEGRATING YOGA WITH A PSYCHOLOGICAL GROUP-TREATMENT IS A SOMEWHAT FEASIBLE APPROACH TO TREATMENT FOR DEPRESSION AND ANXIETY IN PRIMARY HEALTHCARE. 2020 7 1523 73 ISOMETRIC YOGA IMPROVES THE FATIGUE AND PAIN OF PATIENTS WITH CHRONIC FATIGUE SYNDROME WHO ARE RESISTANT TO CONVENTIONAL THERAPY: A RANDOMIZED, CONTROLLED TRIAL. BACKGROUND: PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) OFTEN COMPLAIN OF PERSISTENT FATIGUE EVEN AFTER CONVENTIONAL THERAPIES SUCH AS PHARMACOTHERAPY, COGNITIVE BEHAVIORAL THERAPY, OR GRADED EXERCISE THERAPY. THE AIM OF THIS STUDY WAS TO INVESTIGATE IN A RANDOMIZED, CONTROLLED TRIAL THE FEASIBILITY AND EFFICACY OF ISOMETRIC YOGA IN PATIENTS WITH CFS WHO ARE RESISTANT TO CONVENTIONAL TREATMENTS. METHODS: THIS TRIAL ENROLLED 30 PATIENTS WITH CFS WHO DID NOT HAVE SATISFACTORY IMPROVEMENT AFTER RECEIVING CONVENTIONAL THERAPY FOR AT LEAST SIX MONTHS. THEY WERE RANDOMLY DIVIDED INTO TWO GROUPS AND WERE TREATED WITH EITHER CONVENTIONAL PHARMACOTHERAPY (CONTROL GROUP, N = 15) OR CONVENTIONAL THERAPY TOGETHER WITH ISOMETRIC YOGA PRACTICE THAT CONSISTED OF BIWEEKLY, 20-MINUTE SESSIONS WITH A YOGA INSTRUCTOR AND DAILY IN-HOME SESSIONS (YOGA GROUP, N = 15) FOR APPROXIMATELY TWO MONTHS. THE SHORT-TERM EFFECT OF ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY ADMINISTRATION OF THE PROFILE OF MOOD STATUS (POMS) QUESTIONNAIRE IMMEDIATELY BEFORE AND AFTER THE FINAL 20-MINUTE SESSION WITH THE INSTRUCTOR. THE LONG-TERM EFFECT OF ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY ADMINISTRATION OF THE CHALDER'S FATIGUE SCALE (FS) QUESTIONNAIRE TO BOTH GROUPS BEFORE AND AFTER THE INTERVENTION. ADVERSE EVENTS AND CHANGES IN SUBJECTIVE SYMPTOMS WERE RECORDED FOR SUBJECTS IN THE YOGA GROUP. RESULTS: ALL SUBJECTS COMPLETED THE INTERVENTION. THE MEAN POMS FATIGUE SCORE DECREASED SIGNIFICANTLY (FROM 21.9 +/- 7.7 TO 13.8 +/- 6.7, P < 0.001) AFTER A YOGA SESSION. THE CHALDER'S FS SCORE DECREASED SIGNIFICANTLY (FROM 25.9 +/- 6.1 TO 19.2 +/- 7.5, P = 0.002) IN THE YOGA GROUP, BUT NOT IN THE CONTROL GROUP. IN ADDITION TO THE IMPROVEMENT OF FATIGUE, TWO PATIENTS WITH CFS AND FIBROMYALGIA SYNDROME IN THE YOGA GROUP ALSO REPORTED PAIN RELIEF. FURTHERMORE, MANY SUBJECTS REPORTED THAT THEIR BODIES BECAME WARMER AND LIGHTER AFTER PRACTICING ISOMETRIC YOGA. ALTHOUGH THERE WERE NO SERIOUS ADVERSE EVENTS IN THE YOGA GROUP, TWO PATIENTS COMPLAINED OF TIREDNESS AND ONE OF DIZZINESS AFTER THE FIRST YOGA SESSION WITH THE INSTRUCTOR. CONCLUSIONS: ISOMETRIC YOGA AS AN ADD-ON THERAPY IS BOTH FEASIBLE AND SUCCESSFUL AT RELIEVING THE FATIGUE AND PAIN OF A SUBSET OF THERAPY-RESISTANT PATIENTS WITH CFS. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. 2014 8 450 82 CHANGES IN CIRCULATING MICRORNA AFTER RECUMBENT ISOMETRIC YOGA PRACTICE BY PATIENTS WITH MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: AN EXPLORATIVE PILOT STUDY. BACKGROUND: YOGA IS A REPRESENTATIVE MIND-BODY THERAPY. OUR PREVIOUS STUDIES HAVE DEMONSTRATED THAT ISOMETRIC YOGA (I.E. YOGA PROGRAMS THAT WE DEVELOPED SO INDIVIDUALS CAN PRACTICE YOGA POSES WITH A SELF-ADJUSTABLE ISOMETRIC LOAD) REDUCES THE FATIGUE OF PATIENTS WITH MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS); HOWEVER, THE UNDERLYING MECHANISMS REMAIN UNCLEAR. SEVERAL STUDIES HAVE SUGGESTED THAT THE MICRO-RIBONUCLEIC ACID (MIRNA) EXPRESSION OF ME/CFS PATIENTS IS DIFFERENT FROM THAT OF HEALTHY SUBJECTS. HOWEVER, IT HAS NOT TO DATE BEEN DETERMINED IF THE PRACTICE OF ISOMETRIC YOGA CAN AFFECT MIRNA EXPRESSION. THEREFORE, WE SOUGHT TO INVESTIGATE IF ISOMETRIC YOGA IS ASSOCIATED WITH CHANGES IN THE EXPRESSION LEVELS OF SERUM MIRNA OF PATIENTS WITH ME/CFS. METHODS: THE STUDY INCLUDED NINE PATIENTS WITH ME/CFS WHO FAILED TO SHOW SATISFACTORY IMPROVEMENT AFTER AT LEAST 6 MONTHS OF TREATMENT ADMINISTERED AT OUR HOSPITAL. PATIENTS PRACTICED RECUMBENT ISOMETRIC YOGA FOR 3 MONTHS; THEY MET WITH A YOGA INSTRUCTOR EVERY 2 TO 4 WEEKS AND PARTICIPATED IN DAILY IN-HOME SESSIONS. THE EFFECT OF RECUMBENT ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY COMPARING PRE- AND POST-INTERVENTION SCORES ON THE JAPANESE VERSION OF THE 11-ITEM CHALDER FATIGUE SCALE (CFQ 11). PATIENT BLOOD SAMPLES WERE DRAWN PRE- AND POST-INTERVENTION, JUST PRIOR TO PRACTICING RECUMBENT ISOMETRIC YOGA WITH AN INSTRUCTOR. THE SERUM WAS USED FOR MIRNA ARRAY ANALYSIS WITH KNOWN HUMAN MIRNAS. RESULTS: THE AVERAGE CFQ 11 SCORE DECREASED SIGNIFICANTLY (FROM 25.3 +/- 5.5 TO 17.0 +/- 5.8, P < 0.0001) AFTER PRACTICING RECUMBENT ISOMETRIC YOGA FOR 3 MONTHS. THE MIRNA MICROARRAY ANALYSIS REVEALED THAT FOUR MIRNAS WERE SIGNIFICANTLY UPREGULATED, AND 42 WERE DOWNREGULATED AFTER THE INTERVENTION PERIOD. CONCLUSIONS: THIS EXPLORATIVE PILOT STUDY IS THE FIRST TO DEMONSTRATE CHANGES IN THE SERUM LEVELS OF SEVERAL MIRNAS AFTER REGULAR PRACTICE OF RECUMBENT ISOMETRIC YOGA. THESE MIRNAS MIGHT REPRESENT BIOMARKERS FOR THE FATIGUE-RELIEVING EFFECTS OF ISOMETRIC YOGA OF PATIENTS WITH ME/CFS. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) 000023472. REGISTERED AUG 4, 2016. 2019 9 610 58 DEVELOPMENT OF A RECUMBENT ISOMETRIC YOGA PROGRAM FOR PATIENTS WITH SEVERE CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS: A PILOT STUDY TO ASSESS FEASIBILITY AND EFFICACY. BACKGROUND: OUR PREVIOUS RANDOMIZED CONTROLLED TRIAL DEMONSTRATED THAT ISOMETRIC YOGA IN A SITTING POSITION REDUCES FATIGUE IN PATIENTS WITH CHRONIC FATIGUE SYNDROME/MYALGIC ENCEPHALOMYELITIS (CFS/ME). HOWEVER, SOME PATIENTS EXPERIENCE DIFFICULTIES SITTING OR PRACTICING ISOMETRIC YOGA IN A SITTING POSITION FOR LONG PERIODS. TO DATE, THERAPEUTIC INTERVENTIONS FOR PATIENTS WITH SEVERE SYMPTOMS HAVE NOT BEEN ESTABLISHED. THEREFORE, WE DEVELOPED A RECUMBENT ISOMETRIC YOGA PROGRAM, WHICH TAKES APPROXIMATELY 20 MIN TO COMPLETE, DESIGNED TO REDUCE FATIGUE IN PATIENTS WITH SEVERE CFS/ME. THE AIM OF THIS PILOT STUDY WAS TO ASSESS THE FEASIBILITY, SAFETY, AND USEFULNESS OF THIS PROGRAM. METHODS: THIS PILOT STUDY INCLUDED 12 ADULT PATIENTS WITH CFS/ME. SIX PATIENTS WERE RELUCTANT TO PRACTICE ISOMETRIC YOGA IN A SITTING POSITION BECAUSE OF THE SEVERITY OF THEIR FATIGUE (GROUP 1). THE REMAINING SIX PATIENTS HAD PREVIOUSLY PRACTICED ISOMETRIC YOGA IN A SITTING POSITION (GROUP 2). FOR 3 MONTHS, THE PATIENTS OF BOTH GROUPS PRACTICED RECUMBENT ISOMETRIC YOGA EVERY 2 TO 4 WEEKS WITH A YOGA INSTRUCTOR AND AT HOME ON OTHER DAYS IF THEY COULD. THE SHORT-TERM EFFECTS OF ISOMETRIC YOGA ON FATIGUE WERE ASSESSED USING THE PROFILE OF MOOD STATUS (POMS) QUESTIONNAIRE IMMEDIATELY BEFORE AND AFTER THEIR FINAL SESSION WITH THE YOGA INSTRUCTOR. THE LONG-TERM EFFECTS OF ISOMETRIC YOGA ON FATIGUE WERE ASSESSED USING THE CHALDER FATIGUE SCALE (FS) QUESTIONNAIRE BEFORE AND AFTER THE INTERVENTION PERIOD. ADVERSE EVENTS, SATISFACTION WITH THE PROGRAM, AND PREFERENCE OF YOGA POSITION (SITTING OR RECUMBENT) WERE ALSO RECORDED. RESULTS: ALL SUBJECTS COMPLETED THE INTERVENTION. IN BOTH GROUPS, THE POMS FATIGUE SCORE WAS SIGNIFICANTLY DECREASED AFTER PRACTICING THE 20-MIN YOGA PROGRAM AND THE CHALDER FS SCORE WAS DECREASED SIGNIFICANTLY AFTER THE 3-MONTH INTERVENTION PERIOD. THERE WERE NO SERIOUS ADVERSE EVENTS. ALL SUBJECTS IN GROUP 2 PREFERRED THE RECUMBENT ISOMETRIC YOGA PROGRAM OVER A SITTING YOGA PROGRAM. CONCLUSIONS: THIS STUDY SUGGESTS THAT RECUMBENT ISOMETRIC YOGA IS A FEASIBLE AND ACCEPTABLE TREATMENT FOR PATIENTS WITH CFS/ME, EVEN FOR PATIENTS WHO EXPERIENCE DIFFICULTY PRACTICING ISOMETRIC YOGA IN THE SITTING POSITION. 2017 10 1967 41 SERUM CORTISOL AND BDNF IN PATIENTS WITH MAJOR DEPRESSION-EFFECT OF YOGA. DEPRESSION IS ASSOCIATED WITH LOW SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND ELEVATED LEVELS OF SERUM CORTISOL. YOGA PRACTICES HAVE BEEN ASSOCIATED WITH ANTIDEPRESSANT EFFECTS, INCREASE IN SERUM BDNF, AND REDUCTION IN SERUM CORTISOL. THIS STUDY EXAMINED THE ASSOCIATION BETWEEN SERUM BDNF AND CORTISOL LEVELS IN DRUG-NAIVE PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS, YOGA THERAPY, AND BOTH. FIFTY-FOUR DRUG-NAIVE CONSENTING ADULT OUTPATIENTS WITH MAJOR DEPRESSION (32 MALES) RECEIVED ANTIDEPRESSANTS ONLY (N = 16), YOGA THERAPY ONLY (N = 19), OR YOGA WITH ANTIDEPRESSANTS (N = 19). SERUM BDNF ANDCORTISOL LEVELS WERE OBTAINED BEFORE AND AFTER 3 MONTHS USING A SANDWICH ELISA METHOD. ONE-WAY ANOVA, CHI-SQUARE TEST, AND PEARSON'S CORRELATION TESTS WERE USED FOR ANALYSIS. THE GROUPS WERE COMPARABLE AT BASELINE ON MOST PARAMETERS. SIGNIFICANT IMPROVEMENT IN DEPRESSION SCORES AND SERUM BDNF LEVELS, AND REDUCTION IN SERUM CORTISOL IN THE YOGA GROUPS, HAVE BEEN DESCRIBED IN PREVIOUS REPORTS. A SIGNIFICANT NEGATIVE CORRELATION WAS OBSERVED BETWEEN CHANGE IN BDNF (PRE-POST) AND CORTISOL (PRE-POST) LEVELS IN THE YOGA-ONLY GROUP (R = -0.59, P = 0.008). IN CONCLUSION, YOGA MAY FACILITATE NEUROPLASTICITY THROUGH STRESS REDUCTION IN DEPRESSED PATIENTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE FINDINGS AND DELINEATE THE PATHWAYS FOR THESE EFFECTS. 2016 11 1761 43 POSITIVE THERAPEUTIC AND NEUROTROPIC EFFECTS OF YOGA IN DEPRESSION: A COMPARATIVE STUDY. CONTEXT: THERAPEUTIC EFFECT OF YOGA IN DEPRESSION IS RECOGNIZED. NEUROPLASTIC EFFECTS OF ANTIDEPRESSANT THERAPIES ARE INFERRED BY ELEVATIONS IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF). ROLE OF YOGA IN BOTH THESE EFFECTS HAS NOT BEEN STUDIED. MATERIALS AND METHODS: NON-SUICIDAL, CONSECUTIVE OUT-PATIENTS OF DEPRESSION WERE OFFERED YOGA EITHER ALONE OR WITH ANTIDEPRESSANTS. THE DEPRESSION SEVERITY WAS RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) BEFORE AND AT 3 MONTHS. SERUM BDNF LEVELS WERE MEASURED AT THE SAME TIME POINTS. REPEATED-MEASURES ANALYSIS OF VARIANCE WAS PERFORMED TO LOOK AT CHANGE ACROSS GROUPS WITH RESPECT TO HDRS SCORES AND BDNF LEVELS OVER 3 MONTHS OF FOLLOW-UP. RELATIONSHIP BETWEEN CHANGE IN SERUM BDNF LEVELS AND CHANGE IN HDRS SCORES WAS ASSESSED USING THE PEARSON'S CORRELATION COEFFICIENT. RESULTS: BOTH YOGA GROUPS WERE BETTER THAN DRUGS-ONLY GROUP WITH RESPECT TO REDUCTION IN HDRS SCORES. SERUM BDNF ROSE IN THE TOTAL SAMPLE IN THE 3-MONTH PERIOD. THIS WAS NOT, HOWEVER, DIFFERENT ACROSS TREATMENT GROUPS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN FALL IN HDRS AND RISE IN SERUM BDNF LEVELS IN YOGA-ONLY GROUP (R=0.702; P=0.001), BUT NOT IN THOSE RECEIVING YOGA AND ANTIDEPRESSANTS OR ANTIDEPRESSANTS-ALONE. CONCLUSIONS: NEUROPLASTIC MECHANISMS MAY BE RELATED TO THE THERAPEUTIC MECHANISMS OF YOGA IN DEPRESSION. 2013 12 661 57 EFFECT OF 12 WEEKS OF YOGA TRAINING ON THE SOMATIZATION, PSYCHOLOGICAL SYMPTOMS, AND STRESS-RELATED BIOMARKERS OF HEALTHY WOMEN. BACKGROUND: PREVIOUS STUDIES HAVE SHOWN THAT THE PRACTICE OF YOGA REDUCES PERCEIVED STRESS AND NEGATIVE FEELINGS AND THAT IT IMPROVES PSYCHOLOGICAL SYMPTOMS. OUR PREVIOUS STUDY ALSO SUGGESTED THAT LONG-TERM YOGA TRAINING IMPROVES STRESS-RELATED PSYCHOLOGICAL SYMPTOMS SUCH AS ANXIETY AND ANGER. HOWEVER, LITTLE IS KNOWN ABOUT THE BENEFICIAL EFFECTS OF YOGA PRACTICE ON SOMATIZATION, THE MOST COMMON STRESS-RELATED PHYSICAL SYMPTOMS, AND STRESS-RELATED BIOMARKERS. WE PERFORMED A PROSPECTIVE, SINGLE ARM STUDY TO EXAMINE THE BENEFICIAL EFFECTS OF 12 WEEKS OF YOGA TRAINING ON SOMATIZATION, PSYCHOLOGICAL SYMPTOMS, AND STRESS-RELATED BIOMARKERS. METHODS: WE RECRUITED HEALTHY WOMEN WHO HAD NO EXPERIENCE WITH YOGA. THE DATA OF 24 PARTICIPANTS WHO WERE FOLLOWED DURING 12 WEEKS OF YOGA TRAINING WERE ANALYZED. SOMATIZATION AND PSYCHOLOGICAL SYMPTOMS WERE ASSESSED BEFORE AND AFTER 12 WEEKS OF YOGA TRAINING USING THE PROFILE OF MOOD STATE (POMS) AND THE SYMPTOM CHECKLIST-90-REVISED (SCL-90-R) QUESTIONNAIRES. URINARY 8-HYDROXYDEOXYGUANOSINE (8-OHDG), BIOPYRRIN, AND CORTISOL LEVELS WERE MEASURED AS STRESS-RELATED BIOMARKERS. THE WILCOXON SIGNED-RANK TEST WAS USED TO COMPARE THE STRESS-RELATED BIOMARKERS AND THE SCORES OF QUESTIONNAIRES BEFORE AND AFTER 12 WEEKS OF YOGA TRAINING. RESULTS: AFTER 12 WEEKS OF YOGA TRAINING, ALL NEGATIVE SUBSCALE SCORES (TENSION-ANXIETY, DEPRESSION, ANGER-HOSTILITY, FATIGUE, AND CONFUSION) FROM THE POMS AND SOMATIZATION, ANXIETY, DEPRESSION, AND HOSTILITY FROM THE SCL-90-R WERE SIGNIFICANTLY DECREASED COMPARED WITH THOSE BEFORE STARTING YOGA TRAINING. CONTRARY TO OUR EXPECTATION, THE URINARY 8-OHDG CONCENTRATION AFTER 12 WEEKS OF YOGA TRAINING SHOWED A SIGNIFICANT INCREASE COMPARED WITH THAT BEFORE STARTING YOGA TRAINING. NO SIGNIFICANT CHANGES WERE OBSERVED IN THE LEVELS OF URINARY BIOPYRRIN AND CORTISOL AFTER THE 12 WEEKS OF YOGA TRAINING. CONCLUSIONS: YOGA TRAINING HAS THE POTENTIAL TO REDUCE THE SOMATIZATION SCORE AND THE SCORES RELATED TO MENTAL HEALTH INDICATORS, SUCH AS ANXIETY, DEPRESSION, ANGER, AND FATIGUE. THE PRESENT FINDINGS SUGGEST THAT YOGA CAN IMPROVE SOMATIZATION AND MENTAL HEALTH STATUS AND HAS IMPLICATIONS FOR THE PREVENTION OF PSYCHOSOMATIC SYMPTOMS IN HEALTHY WOMEN. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000007868. 2014 13 2847 52 YOGA, MEDITATION AND MIND-BODY HEALTH: INCREASED BDNF, CORTISOL AWAKENING RESPONSE, AND ALTERED INFLAMMATORY MARKER EXPRESSION AFTER A 3-MONTH YOGA AND MEDITATION RETREAT. THIRTY-EIGHT INDIVIDUALS (MEAN AGE: 34.8 YEARS OLD) PARTICIPATING IN A 3-MONTH YOGA AND MEDITATION RETREAT WERE ASSESSED BEFORE AND AFTER THE INTERVENTION FOR PSYCHOMETRIC MEASURES, BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF), CIRCADIAN SALIVARY CORTISOL LEVELS, AND PRO- AND ANTI-INFLAMMATORY CYTOKINES. PARTICIPATION IN THE RETREAT WAS FOUND TO BE ASSOCIATED WITH DECREASES IN SELF-REPORTED ANXIETY AND DEPRESSION AS WELL AS INCREASES IN MINDFULNESS. AS HYPOTHESIZED, INCREASES IN THE PLASMA LEVELS OF BDNF AND INCREASES IN THE MAGNITUDE OF THE CORTISOL AWAKENING RESPONSE (CAR) WERE ALSO OBSERVED. THE NORMALIZED CHANGE IN BDNF LEVELS WAS INVERSELY CORRELATED WITH BSI-18 ANXIETY SCORES AT BOTH THE PRE-RETREAT (R = 0.40, P < 0.05) AND POST-RETREAT (R = 0.52, P < 0.005) SUCH THAT THOSE WITH GREATER ANXIETY SCORES TENDED TO EXHIBIT SMALLER PRE- TO POST-RETREAT INCREASES IN PLASMA BDNF LEVELS. IN LINE WITH A HYPOTHESIZED DECREASE IN INFLAMMATORY PROCESSES RESULTING FROM THE YOGA AND MEDITATION PRACTICES, WE FOUND THAT THE PLASMA LEVEL OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 WAS INCREASED AND THE PRO-INFLAMMATORY CYTOKINE INTERLEUKIN-12 WAS REDUCED AFTER THE RETREAT. CONTRARY TO OUR INITIAL HYPOTHESES, PLASMA LEVELS OF OTHER PRO-INFLAMMATORY CYTOKINES, INCLUDING INTERFERON GAMMA (IFN-GAMMA), TUMOR NECROSIS FACTOR (TNF-ALPHA), INTERLEUKIN-1BETA (IL-1BETA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-8 (IL-8) WERE INCREASED AFTER THE RETREAT. GIVEN EVIDENCE FROM PREVIOUS STUDIES OF THE POSITIVE EFFECTS OF MEDITATIVE PRACTICES ON MENTAL FITNESS, AUTONOMIC HOMEOSTASIS AND INFLAMMATORY STATUS, WE HYPOTHESIZE THAT THESE FINDINGS ARE RELATED TO THE MEDITATIVE PRACTICES THROUGHOUT THE RETREAT; HOWEVER, SOME OF THE OBSERVED CHANGES MAY ALSO BE RELATED TO OTHER ASPECTS OF THE RETREAT SUCH AS PHYSICAL EXERCISE-RELATED COMPONENTS OF THE YOGA PRACTICE AND DIET. WE HYPOTHESIZE THAT THE PATTERNS OF CHANGE OBSERVED HERE REFLECT MIND-BODY INTEGRATION AND WELL-BEING. THE INCREASED BDNF LEVELS OBSERVED IS A POTENTIAL MEDIATOR BETWEEN MEDITATIVE PRACTICES AND BRAIN HEALTH, THE INCREASED CAR IS LIKELY A REFLECTION OF INCREASED DYNAMIC PHYSIOLOGICAL AROUSAL, AND THE RELATIONSHIP OF THE DUAL ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINE CHANGES TO HEALTHY IMMUNOLOGIC FUNCTIONING IS DISCUSSED. 2017 14 2177 27 THE EFFECTS OF YOGA ON MOOD IN PSYCHIATRIC INPATIENTS. THE EFFECTS OF YOGA ON MOOD WERE EXAMINED IN 13 PSYCHIATRIC INPATIENTS AT NEW HAMPSHIRE HOSPITAL. PARTICIPANTS COMPLETED THE PROFILE OF MOOD STATES (POMS) PRIOR TO AND FOLLOWING PARTICIPATION IN A YOGA CLASS. ANALYSES INDICATED THAT PARTICIPANTS REPORTED SIGNIFICANT IMPROVEMENTS ON ALL FIVE OF THE NEGATIVE EMOTION FACTORS ON THE POMS, INCLUDING TENSION-ANXIETY, DEPRESSION-DEJECTION, ANGER-HOSTILITY, FATIGUE-INERTIA, AND CONFUSION-BEWILDERMENT. THERE WAS NO SIGNIFICANT CHANGE ON THE SIXTH POMS FACTOR, VIGOR-ACTIVITY. IMPROVEMENTS IN MOOD WERE NOT RELATED TO GENDER OR DIAGNOSIS. THE RESULTS SUGGEST THAT YOGA WAS ASSOCIATED WITH IMPROVED MOOD, AND MAY BE A USEFUL WAY OF REDUCING STRESS DURING INPATIENT PSYCHIATRIC TREATMENT. 2005 15 2425 41 YOGA AND NATUROPATHY INTERVENTION FOR REDUCING ANXIETY AND DEPRESSION OF COVID-19 PATIENTS - A PILOT STUDY. BACKGROUND: CORONAVIRUS DISEASE 2019 (COVID-19) INFECTION HAS CAUSED A PROMINENT PSYCHOLOGICAL AND MENTAL HAVOC AMONG THE PATIENTS. TILL NOW, THERE IS PAUCITY IN LITERATURE FOR THE MANAGEMENT OF PSYCHOLOGICAL PROBLEMS AMONG PATIENTS WITH COVID-19. SO WE AIMED IN OUR STUDY TO ASSESS THE EFFECT OF YOGA AND NATUROPATHY INTERVENTION ON ANXIETY AND DEPRESSION OF COVID-19 PATIENTS. METHODS: THIS QUASI EXPERIMENTAL STUDY WAS CONDUCTED AMONG 130 COVID-19 POSITIVE PATIENTS ADMITTED IN A TERTIARY CARE HOSPITAL. YOGA AND NATUROPATHIC INTERVENTION WAS GIVEN FOR 60 MIN A DAY FOR TWO WEEKS. HOSPITAL ANXIETY DEPRESSION SCALE (HADS) AND CORONA ANXIETY SCALE (CAS) WAS USED TO ASSESS THE GENERALIZED ANXIETY AND DEPRESSION AMONG THE PATIENTS. RESULTS: AVERAGE AGE OF THE PATIENTS PARTICIPATED WAS 44 WITH THE RANGE FROM 36 TO 53 YEARS. AMONG THEM 85 WERE MALE AND 45 WERE FEMALE. OF ALL 130 PATIENTS, 33% HAD SYMPTOMS OF BORDERLINE DEPRESSION, 9.2% HAD SEVERE DEPRESSION, 40% HAD BORDERLINE ANXIETY AND 12.3% HAD SEVERE ANXIETY. IN CAS, 59 PATIENTS (45.38%) REPORTED COVID-19 RELATED DYSFUNCTIONAL ANXIETY. ALL THE PATIENTS SHOWED A SIGNIFICANT REDUCTION IN THE HADS- ANXIETY (P < 0.01), HADS-DEPRESSION (P < 0.01) AND CAS (P < 0.01) SCORE AFTER THE INTERVENTION. CONCLUSION: THE PRESENT STUDY SHOWED SIGNIFICANT REDUCTION OF ANXIETY AND DEPRESSION LEVEL AMONG THE COVID-19 PATIENTS. THESE INTERVENTIONS CAN BE ADDED TO THE CONVENTIONAL CARE FOR BETTER MENTAL AND PHYSICAL WELLBEING OF THE PATIENTS AFTER VALIDATING THE FINDINGS WITH JUSTIFIED STUDY DESIGN. 2021 16 1597 35 MEDITATION WITH YOGA, GROUP THERAPY WITH HYPNOSIS, AND PSYCHOEDUCATION FOR LONG-TERM DEPRESSED MOOD: A RANDOMIZED PILOT TRIAL. THIS RANDOMIZED PILOT STUDY INVESTIGATED THE EFFECTS OF MEDITATION WITH YOGA (AND PSYCHOEDUCATION) VERSUS GROUP THERAPY WITH HYPNOSIS (AND PSYCHOEDUCATION) VERSUS PSYCHOEDUCATION ALONE ON DIAGNOSTIC STATUS AND SYMPTOM LEVELS AMONG 46 INDIVIDUALS WITH LONG-TERM DEPRESSIVE DISORDERS. RESULTS INDICATE THAT SIGNIFICANTLY MORE MEDITATION GROUP PARTICIPANTS EXPERIENCED A REMISSION THAN DID CONTROLS AT 9-MONTH FOLLOW-UP. EIGHT HYPNOSIS GROUP PARTICIPANTS ALSO EXPERIENCED A REMISSION, BUT THE DIFFERENCE FROM CONTROLS WAS NOT STATISTICALLY SIGNIFICANT. THREE CONTROL PARTICIPANTS, BUT NO MEDITATION OR HYPNOSIS PARTICIPANTS, DEVELOPED A NEW DEPRESSIVE EPISODE DURING THE STUDY, THOUGH THIS DIFFERENCE DID NOT REACH STATISTICAL SIGNIFICANCE IN ANY CASE. ALTHOUGH ALL GROUPS REPORTED SOME REDUCTION IN SYMPTOM LEVELS, THEY DID NOT DIFFER SIGNIFICANTLY IN THAT OUTCOME. OVERALL, THESE RESULTS SUGGEST THAT THESE TWO INTERVENTIONS SHOW PROMISE FOR TREATING LOW- TO MODERATE-LEVEL DEPRESSION. 2008 17 851 46 EFFECT OF YOGA ON SLEEP QUALITY AND NEUROENDOCRINE IMMUNE RESPONSE IN METASTATIC BREAST CANCER PATIENTS. BACKGROUND: STUDIES HAVE SHOWN THAT DISTRESS AND ACCOMPANYING NEUROENDOCRINE STRESS RESPONSES AS IMPORTANT PREDICTOR OF SURVIVAL IN ADVANCED BREAST CANCER PATIENTS. SOME PSYCHOTHERAPEUTIC INTERVENTION STUDIES HAVE SHOWN HAVE MODULATION OF NEUROENDOCRINE-IMMUNE RESPONSES IN ADVANCED BREAST CANCER PATIENTS. IN THIS STUDY, WE EVALUATE THE EFFECTS OF YOGA ON PERCEIVED STRESS, SLEEP, DIURNAL CORTISOL, AND NATURAL KILLER (NK) CELL COUNTS IN PATIENTS WITH METASTATIC CANCER. METHODS: IN THIS STUDY, 91 PATIENTS WITH METASTATIC BREAST CANCER WHO SATISFIED SELECTION CRITERIA AND CONSENTED TO PARTICIPATE WERE RECRUITED AND RANDOMIZED TO RECEIVE "INTEGRATED YOGA BASED STRESS REDUCTION PROGRAM" (N = 45) OR STANDARD "EDUCATION AND SUPPORTIVE THERAPY SESSIONS" (N = 46) OVER A 3 MONTH PERIOD. PSYCHOMETRIC ASSESSMENTS FOR SLEEP QUALITY WERE DONE BEFORE AND AFTER INTERVENTION. BLOOD DRAWS FOR NK CELL COUNTS WERE COLLECTED BEFORE AND AFTER THE INTERVENTION. SALIVA SAMPLES WERE COLLECTED FOR THREE CONSECUTIVE DAYS BEFORE AND AFTER INTERVENTION. DATA WERE ANALYZED USING THE ANALYSIS OF COVARIANCE ON POSTMEASURES USING RESPECTIVE BASELINE MEASURE AS A COVARIATE. RESULTS: THERE WAS A SIGNIFICANT DECREASE IN SCALES OF SYMPTOM DISTRESS (P < 0.001), SLEEP PARAMETERS (P = 0.02), AND IMPROVEMENT IN QUALITY OF SLEEP (P = 0.001) AND INSOMNIA RATING SCALE SLEEP SCORE (P = 0.001) FOLLOWING INTERVENTION. THERE WAS A DECREASE IN MORNING WAKING CORTISOL IN YOGA GROUP (P = 0.003) ALONE FOLLOWING INTERVENTION. THERE WAS A SIGNIFICANT IMPROVEMENT IN NK CELL PERCENT (P = 0.03) FOLLOWING INTERVENTION IN YOGA GROUP COMPARED TO CONTROL GROUP. CONCLUSION: THE RESULTS SUGGEST MODULATION OF NEUROENDOCRINE RESPONSES AND IMPROVEMENT IN SLEEP IN PATIENTS WITH ADVANCED BREAST CANCER FOLLOWING YOGA INTERVENTION. 2017 18 1308 39 HATHA-YOGA AS A PSYCHOLOGICAL ADJUVANT FOR WOMEN UNDERGOING IVF: A PILOT STUDY. OBJECTIVES: TO EVALUATE THE INFLUENCE OF HATHA-YOGA (HY) PRACTICE ON DISTRESS OF WOMEN BEFORE STARTING THEIR FIRST IN VITRO FERTILIZATION (IVF) CYCLE. STUDY DESIGN: WE OFFERED 143 CONSECUTIVE WOMEN WITH COUPLE INFERTILITY THE OPPORTUNITY TO ATTEND A FREE HY COURSE LASTING 3 MONTHS AS A PSYCHOLOGICAL SUPPORT BEFORE STARTING THEIR FIRST IVF CYCLE. ALL WOMEN WERE ASKED TO COMPLETE THE STATE-TRAIT ANXIETY INVENTORY-Y1 (STAY-Y1), EDINBURGH DEPRESSION SCALE (EDS) AND GENERAL HEALTH QUESTIONNAIRE-12 (GHQ-12) AT BASELINE (T1) AND AFTER 3 MONTHS (T2), TO EVALUATE SYMPTOMS OF ANXIETY, DEPRESSION AND DISTRESS, RESPECTIVELY. RESULTS: OF THE 143 WOMEN, 120 COMPLETED ALL THREE QUESTIONNAIRES. OF THESE, 45 ATTENDED THE HY COURSE AND 75 DID NOT. AT T1, EDS AND GHQ-12 SCORES WERE SIGNIFICANTLY HIGHER IN THE HY GROUP THAN IN THE NON-HY GROUP. THERE WERE NO GROUP DIFFERENCES IN STAI-Y1 SCORES. AT T2 THERE WERE NO GROUP DIFFERENCES. WHEN, IN EACH GROUP, THE SCORE OF EACH QUESTIONNAIRE AT T1 WAS COMPARED TO THE SCORE AT T2, A SIGNIFICANT T1 TO T2 REDUCTION WAS OBSERVED IN THE HY GROUP (P<0.0001 FOR STAY-Y1 AND GHQ-12, P<0.001 FOR EDS). CONCLUSIONS: OUR DATA SUGGEST THAT WOMEN WHO ARE MORE DISTRESSED ARE MORE LIKELY TO ACCEPT PSYCHOLOGICAL SUPPORT BEFORE STARTING AN IVF CYCLE AND THAT IN THESE WOMEN HY PRACTICE IS ASSOCIATED WITH DISTRESS REDUCTION. 2014 19 180 33 A RANDOMIZED CONTROLLED TRIAL OF YOGA FOR PREGNANT WOMEN WITH SYMPTOMS OF DEPRESSION AND ANXIETY. BACKGROUND: YOGA MAY BE WELL SUITED FOR DEPRESSED AND ANXIOUS PREGNANT WOMEN, GIVEN REPORTED BENEFITS OF MEDITATION AND PHYSICAL ACTIVITY AND PREGNANT WOMEN'S PREFERENCE FOR NONPHARMACOLOGICAL TREATMENTS. METHODS: WE RANDOMLY ASSIGNED 46 PREGNANT WOMEN WITH SYMPTOMS OF DEPRESSION AND ANXIETY TO AN 8-WEEK YOGA INTERVENTION OR TREATMENT-AS-USUAL (TAU) IN ORDER TO EXAMINE FEASIBILITY AND PRELIMINARY OUTCOMES. RESULTS: YOGA WAS ASSOCIATED WITH HIGH LEVELS OF CREDIBILITY AND SATISFACTION AS AN INTERVENTION FOR DEPRESSION AND ANXIETY DURING PREGNANCY. PARTICIPANTS IN BOTH CONDITIONS REPORTED SIGNIFICANT IMPROVEMENT IN SYMPTOMS OF DEPRESSION AND ANXIETY OVER TIME; AND YOGA WAS ASSOCIATED WITH SIGNIFICANTLY GREATER REDUCTION IN NEGATIVE AFFECT AS COMPARED TO TAU (BETA = -0.53, SE = 0.20, P = .011). CONCLUSION: PRENATAL YOGA WAS FOUND TO BE A FEASIBLE AND ACCEPTABLE INTERVENTION AND WAS ASSOCIATED WITH REDUCTIONS IN SYMPTOMS OF ANXIETY AND DEPRESSION; HOWEVER, PRENATAL YOGA ONLY SIGNIFICANTLY OUTPERFORMED TAU ON REDUCTION OF NEGATIVE AFFECT. 2015 20 962 38 EFFECTS OF A YOGA PROGRAM ON CORTISOL RHYTHM AND MOOD STATES IN EARLY BREAST CANCER PATIENTS UNDERGOING ADJUVANT RADIOTHERAPY: A RANDOMIZED CONTROLLED TRIAL. UNLABELLED: OBJECTIVES. THIS STUDY COMPARES THE EFFECTS OF AN INTEGRATED YOGA PROGRAM WITH BRIEF SUPPORTIVE THERAPY IN BREAST CANCER OUTPATIENTS UNDERGOING ADJUVANT RADIOTHERAPY AT A CANCER CENTER. METHODS: EIGHTY-EIGHT STAGE II AND III BREAST CANCER OUTPATIENTS ARE RANDOMLY ASSIGNED TO RECEIVE YOGA (N = 44) OR BRIEF SUPPORTIVE THERAPY (N = 44) PRIOR TO RADIOTHERAPY TREATMENT. ASSESSMENTS INCLUDE DIURNAL SALIVARY CORTISOL LEVELS 3 DAYS BEFORE AND AFTER RADIOTHERAPY AND SELF-RATINGS OF ANXIETY, DEPRESSION, AND STRESS COLLECTED BEFORE AND AFTER 6 WEEKS OF RADIOTHERAPY. RESULTS: ANALYSIS OF COVARIANCE REVEALS SIGNIFICANT DECREASES IN ANXIETY (P < .001), DEPRESSION (P = .002), PERCEIVED STRESS (P < .001), 6 A.M. SALIVARY CORTISOL (P = .009), AND POOLED MEAN CORTISOL (P = .03) IN THE YOGA GROUP COMPARED WITH CONTROLS. THERE IS A SIGNIFICANT POSITIVE CORRELATION BETWEEN MORNING SALIVARY CORTISOL LEVEL AND ANXIETY AND DEPRESSION. CONCLUSION: YOGA MIGHT HAVE A ROLE IN MANAGING SELF-REPORTED PSYCHOLOGICAL DISTRESS AND MODULATING CIRCADIAN PATTERNS OF STRESS HORMONES IN EARLY BREAST CANCER PATIENTS UNDERGOING ADJUVANT RADIOTHERAPY. 2009